NBIX
Neurocrine Biosciences, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$155.64
−1.71%0
Insider buys (3m)
15
Insider sells (3m)
-$11.5M
Net value (3m)
-4.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 30, 2026 | Norwalk Leslie V · director | Sale | 1,250 | $182 |
| Jul 30, 2026 | Norwalk Leslie V · director | M-Exempt | 842 | $139 |
| Jul 13, 2026 | Delaet Ingrid · officer: Chief Regulatory Officer | M-Exempt | 4,367 | $106 |
| Jul 13, 2026 | Lippoldt Darin · officer: Chief Legal Officer | M-Exempt | 10,000 | $81 |
| Jul 13, 2026 | Lippoldt Darin · officer: Chief Legal Officer | Sale | 10,000 | $180 |
| Jul 13, 2026 | Delaet Ingrid · officer: Chief Regulatory Officer | Sale | 4,367 | $181 |
| Jul 9, 2026 | Delaet Ingrid · officer: Chief Regulatory Officer | M-Exempt | 8,433 | $104 |
| Jul 9, 2026 | Delaet Ingrid · officer: Chief Regulatory Officer | M-Exempt | 2,737 | $104 |
| Jul 9, 2026 | Delaet Ingrid · officer: Chief Regulatory Officer | Sale | 8,433 | $179 |
| Jul 9, 2026 | Delaet Ingrid · officer: Chief Regulatory Officer | Sale | 2,737 | $179 |
| Jul 9, 2026 | Delaet Ingrid · officer: Chief Regulatory Officer | M-Exempt | 3,401 | $104 |
| Jul 9, 2026 | Delaet Ingrid · officer: Chief Regulatory Officer | Sale | 3,401 | $179 |
| Jun 30, 2026 | Lippoldt Darin · officer: Chief Legal Officer | M-Exempt | 200 | $81 |
| Jun 30, 2026 | Lippoldt Darin · officer: Chief Legal Officer | Sale | 200 | $170 |
| Jun 30, 2026 | Lippoldt Darin · officer: Chief Legal Officer | M-Exempt | 1,690 | $81 |
| Jun 30, 2026 | Lippoldt Darin · officer: Chief Legal Officer | Sale | 1,690 | $171 |
| Jun 30, 2026 | Lippoldt Darin · officer: Chief Legal Officer | Sale | 8,110 | $170 |
| Jun 30, 2026 | Lippoldt Darin · officer: Chief Legal Officer | M-Exempt | 8,110 | $81 |
| Jun 9, 2026 | SHERWIN STEPHEN A · director | Sale | 1,843 | $167 |
| Jun 9, 2026 | SHERWIN STEPHEN A · director | Sale | 2,549 | $164 |
| Jun 9, 2026 | SHERWIN STEPHEN A · director | Sale | 6,896 | $166 |
| Jun 9, 2026 | SHERWIN STEPHEN A · director | Sale | 5,829 | $167 |
| Jun 9, 2026 | SHERWIN STEPHEN A · director | Sale | 7,883 | $164 |
| Jun 9, 2026 | SHERWIN STEPHEN A · director | M-Exempt | 10,000 | $80 |
| Jun 9, 2026 | SHERWIN STEPHEN A · director | M-Exempt | 15,000 | $54 |
| Jun 8, 2026 | Norwalk Leslie V · director | Sale | 1,250 | $168 |
| Jun 4, 2026 | Keswani Sanjay Chandru · officer: Chief Medical Officer | M-Exempt | 3,212 | $0.00 |
| Jun 4, 2026 | Cooke Julie · officer: Chief Human Resources Officer | Sale | 14,214 | $155 |
| Jun 4, 2026 | Keswani Sanjay Chandru · officer: Chief Medical Officer | F-InKind | 1,733 | $155 |
| Jun 4, 2026 | Cooke Julie · officer: Chief Human Resources Officer | Sale | 9,521 | $158 |
Institutional positioning
13F filings over the trailing two quarters
New 235Increased 616Reduced 453Sold out 67
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 13,711,607 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 13,385,607 | May 13, 2026 |
| JPMORGAN CHASE & CO | Increased | 6,398,674 | Aug 12, 2026 |
| DODGE & COX | Increased | 5,584,707 | Aug 13, 2026 |
| DODGE & COX | Reduced | 5,461,037 | May 14, 2026 |
| JPMORGAN CHASE & CO | Increased | 5,442,067 | May 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 4,974,083 | Aug 13, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 4,938,967 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4,726,344 | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,545,339 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4,511,904 | May 15, 2026 |
| STATE STREET CORP | Increased | 4,385,598 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 4,354,526 | May 15, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Reduced | 3,818,037 | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 3,060,570 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 30, 2026